Dark

Check out our API

DAWN
Day One Biopharmaceuticals, Inc. Common Stock
stock NASDAQ

Inactive

Apr 22, 2026

21.53USD+0.186%(+0.04)2,988,827

Pre-market

0.00USD-100.000%(-21.49)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 5, 2022

08:01AM EST Day One to Present at the 40th Annual J.P. Morgan Healthcare GlobeNewswire Inc

Nov 22, 2021

07:11AM EST Day One Doses First Patient In Phase 2 Monotherapy Study In RAF-altered Solid Tumors RTTNews

07:04AM EST Day One Announces First Patient Dosed In Phase 2 Monotherapy Study In RAF-altered Solid Tumors Benzinga

07:00AM EST -- Phase 1b/2 Study Evaluating DAY101 in Combination with Pimasertib, Day Ones MEK Inhibitor, Expected to Begin in First Quarter of 2022 GlobeNewswire Inc

Nov 18, 2021

08:00AM EST Day One to Present at the Piper Sandler 33rd Annual Virtual GlobeNewswire Inc

Nov 9, 2021

11:14AM EST Day One Biopharmaceutical Q3 EPS $(0.33) Up From $(0.50) YoY Benzinga

Nov 3, 2021

08:00AM EDT Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers, today announced an upcoming poster presentation at the 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting, being held from November 10-13, 2021. GlobeNewswire Inc

Sep 13, 2021

07:00AM EDT Day One Appoints Jaa Roberson as Chief People Officer GlobeNewswire Inc

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Aug 27, 2021

07:35AM EDT The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration Benzinga

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 17, 2021

07:00AM EDT Day One Appoints Scott Garland to Board of Directors GlobeNewswire Inc

Aug 10, 2021

04:50PM EDT Day One Biopharmaceutical Q2 EPS $(5.04) Down From $(0.32) YoY Benzinga

04:05PM EDT Day One Reports Second Quarter 2021 Financial Results and GlobeNewswire Inc

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 4, 2021

08:00AM EDT Day One Biopharmaceuticals to Participate at the 2021 Wedbush GlobeNewswire Inc

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

11:13AM EDT Day One Receives FDA Rare Pediatric Disease Designation For DAY101 For Treatment Of Pediatric Low-Grade Glioma Benzinga

Jun 21, 2021

10:15AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021 Benzinga

07:30AM EDT Cowen & Co. Initiates Coverage On Day One Biopharmaceutical with Outperform Rating Benzinga

07:25AM EDT Wedbush Initiates Coverage On Day One Biopharmaceutical with Outperform Rating, Announces Price Target of $30 Benzinga

07:04AM EDT Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma Benzinga

07:00AM EDT Day One Receives Orphan Designation from the European Commission GlobeNewswire Inc

05:23AM EDT JP Morgan Initiates Coverage On Day One Biopharmaceutical with Overweight Rating, Announces Price Target of $38 Benzinga

05:15AM EDT Piper Sandler Initiates Coverage On Day One Biopharmaceutical with Overweight Rating, Announces Price Target of $44 Benzinga

Jun 4, 2021

09:39AM EDT The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact Benzinga

Jun 2, 2021

08:20AM EDT The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements Benzinga

Jun 1, 2021

04:01PM EDT Day One Announces Closing of Upsized Initial Public Offering and GlobeNewswire Inc

May 27, 2021

11:16AM EDT Day One Biopharma Shares Open For Trade At $25; IPO Priced At $16/Share Benzinga

10:40AM EDT Day One Biopharmaceuticals Shares Indicating $23.01 Benzinga

09:20AM EDT Day One Biopharmaceuticals Shares Will Open For Quote At 9:50 a.m. EDT, Expected To Open For Trade After 10 a.m. EDT; IPO Priced $16/Share Benzinga

May 26, 2021

10:30PM EDT Day One Announces Pricing of Upsized Initial Public Offering GlobeNewswire Inc

Share